Brett P. Monia
Known title: Chief Executive OfficerCIK: 0001537529
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Cognition Therapeutics Sets FDA Type C Meeting for Oct. 20. Cognition Therapeutics announced it will hold a Type C meeting with the FDA on October 20 regarding the planned trial of zervimesine. This regulatory step is a key milestone for the drug's development path. The company's stock currently trades within a wide 52-week range, reflecting the uncertainty typical of clinical-stage biotech firms.
Transaction History
| IONS | ▼ Sell | Other | 98 | $5K | 8/31/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 50,000 | $2.8M | 6/26/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 50,000 | $4.0M | 6/26/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 21,072 | $687K | 6/25/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 21,072 | $1.7M | 6/25/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 14,565 | $475K | 6/24/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 14,565 | $1.1M | 6/24/2026 | View on chart |
| CGTX | ▲ Buy | Grant | 25,000 | $0 | 6/17/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 3,220 | $105K | 5/14/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 3,220 | $253K | 5/14/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 1,316 | $43K | 5/13/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 1,316 | $103K | 5/13/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 34,103 | $2.1M | 3/10/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 16,512 | $1.2M | 3/10/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 17,591 | $1.3M | 3/10/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 40,822 | $2.5M | 3/9/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 73,529 | $4.5M | 3/9/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 7,382 | $547K | 3/9/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 117,604 | $8.9M | 3/9/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 1,684 | $127K | 3/9/2026 | View on chart |
| IONS | ▼ Sell | Other | 484 | $24K | 2/27/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 29,430 | $2.5M | 2/6/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 62,970 | $5.2M | 1/30/2026 | View on chart |
| IONS | ▲ Buy | Grant | 122,214 | $0 | 1/29/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 44,034 | $3.3M | 1/16/2026 | View on chart |
| IONS | ▲ Buy | Option Exercise | 89,145 | $0 | 1/15/2026 | View on chart |
| IONS | ▼ Sell | Open Market | 437 | $30K | 10/6/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 31,316 | $1.0M | 9/3/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 27,568 | $899K | 9/3/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 59,699 | $3.6M | 9/3/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 102,900 | $5.5M | 9/3/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 16,615 | $982K | 9/3/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 42,030 | $1.6M | 9/3/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 127,500 | $7.7M | 9/3/2025 | View on chart |
| IONS | ▼ Sell | Other | 189 | $5K | 8/29/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 2,432 | $79K | 7/30/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 2,432 | $109K | 7/30/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 1,160 | $48K | 7/11/2025 | View on chart |
| CGTX | ▲ Buy | Grant | 34,000 | $0 | 6/18/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 140 | $5K | 3/11/2025 | View on chart |
| IONS | ▼ Sell | Other | 437 | $12K | 2/28/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 38,843 | $1.2M | 2/4/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 13,242 | $430K | 1/31/2025 | View on chart |
| IONS | ▲ Buy | Grant | 25,372 | $0 | 1/30/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 33,445 | $1.1M | 1/16/2025 | View on chart |
| IONS | ▲ Buy | Option Exercise | 73,448 | $0 | 1/15/2025 | View on chart |
| IONS | ▼ Sell | Open Market | 6,630 | $252K | 11/12/2024 | View on chart |
| IONS | ▼ Sell | Other | 140 | $5K | 8/30/2024 | View on chart |
| CGTX | ▲ Buy | Grant | 8,500 | $0 | 6/7/2024 | View on chart |
| IONS | ▼ Sell | Other | 538 | $19K | 2/29/2024 | View on chart |
| IONS | ▼ Sell | Open Market | 387 | $17K | 2/16/2024 | View on chart |
| IONS | ▼ Sell | Open Market | 23,501 | $1.2M | 2/2/2024 | View on chart |
| IONS | ▲ Buy | Grant | 20,416 | $0 | 2/1/2024 | View on chart |
| IONS | ▲ Buy | Grant | 25,372 | $0 | 2/1/2024 | View on chart |
| IONS | ▼ Sell | Open Market | 2,285 | $118K | 1/25/2024 | View on chart |
| IONS | ▼ Sell | Open Market | 32,059 | $1.6M | 1/17/2024 | View on chart |
| IONS | ▲ Buy | Option Exercise | 68,084 | $0 | 1/16/2024 | View on chart |
| IONS | ▲ Buy | Option Exercise | 17,500 | $828K | 12/21/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 17,500 | $863K | 12/21/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 6,500 | $308K | 12/20/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 6,500 | $323K | 12/20/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 14,860 | $703K | 12/14/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 14,860 | $731K | 12/14/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 9,140 | $433K | 12/14/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 9,140 | $459K | 12/14/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 3,770 | $173K | 10/12/2023 | View on chart |
| IONS | ▼ Sell | Other | 157 | $5K | 8/31/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 18,650 | $788K | 7/7/2023 | View on chart |
| CGTX | ▲ Buy | Grant | 6,000 | $0 | 6/9/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 2,301 | $92K | 5/22/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 2,630 | $106K | 5/22/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 24,651 | $1.0M | 2/6/2023 | View on chart |
| IONS | ▲ Buy | Grant | 6,511 | $0 | 2/3/2023 | View on chart |
| IONS | ▲ Buy | Grant | 17,210 | $0 | 2/3/2023 | View on chart |
| IONS | ▲ Buy | Grant | 25,372 | $0 | 2/3/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 25,066 | $990K | 1/18/2023 | View on chart |
| IONS | ▲ Buy | Option Exercise | 57,267 | $0 | 1/17/2023 | View on chart |
| IONS | ▼ Sell | Open Market | 355 | $13K | 4/1/2022 | View on chart |
| IONS | ▼ Sell | Other | 621 | $18K | 2/28/2022 | View on chart |
| IONS | ▲ Buy | Grant | 2,194 | $0 | 1/26/2022 | View on chart |
| IONS | ▼ Sell | Tax Withholding | 8,032 | $253K | 1/26/2022 | View on chart |
| IONS | ▲ Buy | Grant | 14,004 | $0 | 1/26/2022 | View on chart |
| IONS | ▲ Buy | Option Exercise | 49,475 | $0 | 1/18/2022 | View on chart |
| IONS | ▼ Sell | Tax Withholding | 19,714 | $594K | 1/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Cathie Wood adds to Ionis position amid RNA sector interest
Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.
Cathie Wood adds to Ionis position amid RNA sector interest. Cathie Wood has increased her holdings in Ionis Pharmaceuticals as part of a broader bet on two stocks. This move highlights continued investor interest in RNA therapeutics, a sector currently drawing attention for its innovation potential. While the stock is trading near its 52-week low, the average analyst target remains significantly higher than the current price.